Alert detail

LCD L39230: MolDX: Plasma-Based Genomic Profiling in Solid Tumors — Noridian

Policy ID: LCD-L39230Specialty: OncologyAdded: 6/5/2026Effective: February 5, 2026lcd
Routine

What changed

New LCD may transform oncology billing with advanced testing.

Who’s affected: Oncology billing teams · Effective: February 5, 2026

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 15 billing codes.

The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.